 phase recombin human interferon-alpha human lymphoblastoid interferon-alpha concomit zidovudin patient aids-rel kaposi sarcoma safeti maximum dose preliminari efficaci concomit interferon-alpha zidovudin therapi aids-rel kaposi sarcoma KS patient biopsy-proven KS human immunodefici viru type hiv infect phase interferon-alpha dose mu day zidovudin mg week mainten period major toxic neutropenia hepatotox neutropenia dose mg zidovudine/day dose interferon-alpha mu/day hepatotox dose mu interferon mg zidovudine/day cumul dose-rel anemia neutropenia long-term follow-up maximum toler dose combin mu interferon-alpha mg zidovudin variabl chang lymphocyt first week therapi dose combin increas median lymphocyt number hiv antigenem patient progress antigen suppress dose combin overal antitumor respons rate tumor regress surviv benefit pretreat cell count equal conclus intermedi dose interferon-alpha dose zidovudin diseas improv surviv benefit